jCyte
CA - Newport Beach
BiotechnologyFocus: Progenitor cell-based technology in retinal diseases
jCyte is a life sciences company focused on Progenitor cell-based technology in retinal diseases.
Ophthalmology
Funding Stage
PUBLIC
Total Funding
$30M
Open Jobs
1
Pipeline & Clinical Trials
human retinal progenitor cells
Retinitis Pigmentosa (RP)Clinical Trials (1)
NCT02320812Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa
Phase 1/2human retinal progenitor cells
Retinitis PigmentosaClinical Trials (1)
NCT03073733Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa
Phase 2human retinal progenitor cells
Retinitis PigmentosaClinical Trials (1)
NCT06912633Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
Phase 2human retinal progenitor cells
Retinitis PigmentosaClinical Trials (1)
NCT04604899Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa
Phase 2Open Jobs (1)
Interview Prep Quick Facts
Portfolio: 4 clinical trials
Open Roles: 1 active job